definiens: shall mean the gross amounts invoiced for sales or other dispositions of Products by or on behalf of SymBio or any of its Related Parties ( each, a ) to Third Parties ( other than Related Parties ), less the following deductions actually incurred, allowed, paid or accrued by the Selling Party and specifically attributable to Products, all in complia nce with applicable Accounting Standards, consistently applied by the Selling Party : ( a ) normal and customary trade discounts, including trade, cash and quantity discounts or rebates credits or refunds, actually allowed or taken ; ( b ) credits or allow ances actually granted or made for rejection of or return of previously sold Products, including recalls, or for retroactive price reductions and billing errors or for stocking allowances ; ( c ) governmental and other rebates ( or credits or other equivale nts thereof ) actually granted to managed health care organizations, commercial insurance companies, pharmacy benefit managers ( or equivalents thereof ), distributors, national, state / provincial, local, and other governments, their agencies and purchasers, a nd reimbursers, or to trade customers, in each case with respect to Product ; ( d ) reasonable fees paid to wholesalers, distributors, selling agents ( excluding sales representatives of the Selling Party ), group purchasing organizations, Third -Party payors, other contractees and managed care entities, in each case with respect to the Prod uct ; ( e ) charges separately invoiced for freight, insurance, transportation, postage and handling ; ( f ) taxes, custom duties or other governmental charges ( including any tax such as a value added or similar tax or government charge but excluding what is commonly known as income tax ) levied on or measured by the billing amount for Products, as adjusted for rebates and refunds ; and ( g ) the amount of any actual write -offs for bad debt on previously sold Product in accordance with the applicable Accoun ting Standards used by the Selling Party, consistently applied, not to exceed [ * ] in any calendar quarter ; provided that any amount written off that is subsequently collected shall be treated as Net Sales in the calendar quarter in which it is collected ; provided that, in each case ( ( a ) through ( g ) ): ( 1 ) each such deduction is calculated in a manner consistent with the Selling Party ’s customary practice for pharmaceutical products and in accordance with applicable Accounting Standards, consistently applied by the Selling Party ; ( 2 ) each such -8- [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both ( i ) not material and ( ii ) would be competitively harmful if publicly disclosed